Abstract:
The invention relates to an end wall module for a transport vehicle. The inventive end wall module having a first wall and the second wall arranged at a distance therefrom. The first wall is embodied in the form of a first corrugated structure and the second wall is embodied in the form of a second corrugated structure. Said corrugated structures are embodied in such a way that they are distanced from each other when the end wall module is mounted without being deformed and are engaged into each other by the shape thereof when the end wall module is at least in the first deformation stage.
Abstract:
The invention relates to a device for an inherently safe signal matching of signals being exchanged between an automating system (2) and field devices (3). The device (1) contains input/output modules (4), which can be plugged into a backwall plate (19) and which combine the functions of conventional input/output modules and modules for voltage separation. The backwall plate (19) supports data lines (20) of a local bus (8), as well a current supply lines (21). A communications module (9) is connected on the one hand with the local bus (8), and on the other hand with a field bus (12). The communications module (9) contains device, for memorizing (22) and processing (16) data, and makes possible an asynchronous data exchange between an automating system (2) and the input/output modules (4).
Abstract:
The present invention provides a method for the determination of a component of an immune reaction in a plasma sample using an immunoassay at a temperature of from 15.degree. to 40.degree. C., where one of the reactive components is in solid phase. The invention involves adding an amount of plasminogen activator sufficient to eliminate interference by fibrinogen with the component to be determined.
Abstract:
The present invention provides a dry reagent for blood coagulation tests in which an at least partial course of the coagulation cascade takes place, comprising a carrier material which contains a chromophoric substrate of a protease of the blood coagulation system, at least one factor and/or co-factor of the blood coagulation system and a buffer.
Abstract:
The present invention provides a process for the simultaneous determination of fibrinogen and fibrinogen fission products in plasma, wherein 0.01 to 1 U of a snake venom enzyme with a thrombin-like effectiveness is aded per ml. of sample plasma, then there is measured the period of time between the addition of the enzyme and the commencement of a turbidity formation as a measure for the amount of fibrinogen fission products and subsequently there is measured the speed of the turbidity formation as a measure of the amount of fibrinogen.The present invention also provides a reagent for the simultaneous determination of fibrinogen and fibrinogen fission products, wherein it comprises 0.01 to 10 U snake venon enzyme with thrombin-like effectiveness per ml. of sample plasma, 0.5 to 4% by weight of a water-soluble polyalcohol, 1 to 20 mMole/liter of calcium ions and 0.05 to 0.3 mole/liter of buffer of pH 7.0 to 8.0, referred to the solution ready for use, as well as optionally a detergent.
Abstract:
An agent for determining ristocetin cofactor (v.Willebrand factor) is described, which contains platelets which have been treated with a tanning agent, with a protease inhibitor and, optionally, with a dye-stuff, and ristocetin A.
Abstract:
The present invention provides a process for the detection or determination of fibrin monomer in biological fluids, wherein the sample fluid is incubated with hydrophobic latex and the agglutination determined.The present invention also provides a reagent for the detection or determination of fibrin or fibrin monomer in biological fluids, wherein it contains hydrophobic latex.
Abstract:
Process for the manufacture of a collagen solution and its use for the manufacture of collagen fibrillae for adsorbing coagulation factors, as diagnostic agent, for the manufacture of a collagen sponge and for use in a cosmetic preparation.